| Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors (NCT04717375) | Sanofi | 2021-04-11 |
| Multimodal Artificial Intelligence for Detecting the Psychological State of Cancer Patients (NCT07751757) | Chinese PLA General Hospital | 2021-03-01 |
| Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation (NCT04142567) | Assistance Publique - Hôpitaux de Paris | 2020-02-11 |
| Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis (NCT04203524) | King Hussein Cancer Center | 2019-08-21 |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers (NCT03547037) | Janssen Pharmaceutical K.K. | 2018-08-31 |
| Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies (NCT03637764) | Sanofi | 2018-08-06 |
| A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126) | Asana BioSciences | 2018-01-19 |
| A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors (NCT03251924) | Bristol-Myers Squibb | 2017-09-01 |
| Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) (NCT03099161) | Merck Sharp & Dohme LLC | 2017-06-27 |
| Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy (NCT02828449) | Institut de Cancérologie de la Loire | 2016-11-01 |
| A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer (NCT02747342) | Atridia Pty Ltd. | 2016-09-01 |
| A Phase I Trial of HS-10241 in Solid Tumors (NCT02759640) | Atridia Pty Ltd. | 2016-09-01 |
| Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban (NCT02746185) | Assistance Publique - Hôpitaux de Paris | 2016-09-01 |
| Natural History of and Specimen Banking for People With Tumors of the Central Nervous System (NCT02851706) | National Cancer Institute (NCI) | 2016-09-01 |
| Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data (NCT02875327) | National Cancer Institute (NCI) | 2016-08-05 |
| The Drug Rediscovery Protocol (DRUP Trial) (NCT02925234) | The Netherlands Cancer Institute | 2016-08-01 |
| A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma (NCT02699606) | Janssen Research & Development, LLC | 2016-07-08 |
| A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors (NCT02759666) | Atridia Pty Ltd. | 2016-06-01 |
| A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors (NCT02743637) | SynDevRx, Inc. | 2016-02-01 |
| Gorbly Compression Device for Use in Image-guided Procedures (NCT02578667) | University of Miami | 2015-12-01 |
| A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers (NCT02514603) | Eli Lilly and Company | 2015-10-01 |
| A Study of LY3023414 in Japanese Participants With Advanced Cancer (NCT02536586) | Eli Lilly and Company | 2015-09-01 |
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors (NCT02440685) | Asana BioSciences | 2015-05-01 |
| A Study of Galunisertib on the Immune System in Participants With Cancer (NCT02304419) | Eli Lilly and Company | 2015-05-01 |
| A Study of Olaratumab in Japanese Participants With Advanced Cancer (NCT02377752) | Eli Lilly and Company | 2015-03-23 |
| Effect of an Early Mobilization Program on Outcomes After Major Cancer Surgery (NCT01693172) | Instituto do Cancer do Estado de São Paulo | 2014-12-01 |
| A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors (NCT02354547) | SynerGene Therapeutics, Inc. | 2014-12-01 |
| The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN). (NCT02309164) | University of Sao Paulo | 2014-09-01 |
| Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy (NCT02044536) | Chuncheon Sacred Heart Hospital | 2014-01-01 |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors (NCT01962103) | Celgene | 2013-12-04 |
| A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) (NCT01920061) | Pfizer | 2013-09-10 |
| Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide (NCT02394821) | University of Sao Paulo | 2013-09-01 |
| Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas (NCT01794104) | National Cancer Institute (NCI) | 2013-02-15 |
| Epidemiological Study of Colorectal Cancer in WuHan (NCT01863303) | Wuhan Pu-Ai Hospital | 2012-06-01 |
| A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors (NCT01517464) | SynerGene Therapeutics, Inc. | 2012-01-01 |
| Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma (NCT01425008) | Millennium Pharmaceuticals, Inc. | 2011-09-15 |
| ECI301 and Radiation for Advanced or Metastatic Cancer (NCT01441115) | National Cancer Institute (NCI) | 2011-09-06 |
| Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions (NCT01457196) | UNC Lineberger Comprehensive Cancer Center | 2011-09-01 |
| Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases (NCT01395407) | Emory University | 2011-07-01 |
| The Use of Angiotensin Receptor Blockers and the Risk of Cancer (NCT02215733) | Boehringer Ingelheim | 2011-02-01 |
| Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures (NCT01287013) | National Institutes of Health Clinical Center (CC) | 2011-01-01 |
| Evaluating Biobanking Educational Tools (NCT01672944) | H. Lee Moffitt Cancer Center and Research Institute | 2010-09-27 |
| Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors (NCT01155713) | Novartis Pharmaceuticals | 2010-07-01 |
| Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy (NCT01287286) | Chang Gung Memorial Hospital | 2010-06-01 |
| EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients (NCT01942005) | Andreas Arnold | 2010-01-01 |
| Use of PET Imaging to Distinguish Malignant From Benign IPMN (NCT01104116) | Columbia University | 2009-09-01 |
| Facts and Attitudes About Clinical Trials (NCT01269645) | H. Lee Moffitt Cancer Center and Research Institute | 2009-07-01 |
| Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients (NCT00961831) | Bayer | 2009-04-15 |
| Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) (NCT01104077) | Columbia University | 2008-11-17 |
| Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009) (NCT00694356) | Merck Sharp & Dohme LLC | 2008-08-04 |
| Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) (NCT00936104) | University Hospital, Gasthuisberg | 2008-08-01 |
| Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED) (NCT00694083) | Merck Sharp & Dohme LLC | 2008-06-10 |
| Study of TRC102 in Combination With Pemetrexed in Cancer Patients (NCT00692159) | Tracon Pharmaceuticals Inc. | 2008-06-01 |
| Study of Pegylated Human Recombinant Arginase for Liver Cancer (NCT00988195) | Bio-Cancer Treatment International Limited | 2008-05-01 |
| Family-supported Smoking Cessation for Chronically Ill Veterans (NCT00448344) | US Department of Veterans Affairs | 2008-02-01 |
| Safety Study of Infusion of SGT-53 to Treat Solid Tumors (NCT00470613) | SynerGene Therapeutics, Inc. | 2008-02-01 |
| The Samsung Medical Center Comprehensive Cancer Center Registry from 2008 to 2023 (NCT06703957) | Samsung Medical Center | 2008-01-01 |
| Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery (NCT00747292) | Minimal Access Therapy Training Unit | 2007-12-01 |
| Study of ADI-PEG 20 in Patients With Advanced Melanoma (NCT00520299) | Ludwig Institute for Cancer Research | 2007-07-01 |
| MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) (NCT00496353) | Merck Sharp & Dohme LLC | 2007-06-01 |
| A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine (NCT00505414) | Grünenthal GmbH | 2007-06-01 |
| Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies (NCT01117623) | Bayer | 2007-02-01 |
| Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products (NCT00695279) | St. Jude Children's Research Hospital | 2007-01-04 |
| A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors (NCT01105533) | Pfizer | 2006-05-01 |
| Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer (NCT00321958) | University of Maryland, Baltimore | 2006-04-01 |
| Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms (NCT00408018) | Piramal Enterprises Limited | 2006-03-01 |
| PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma (NCT00226005) | Pancreatic Cancer Research Team | 2005-12-01 |
| Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms (NCT00407498) | Piramal Enterprises Limited | 2005-05-01 |
| Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer (NCT00100139) | INSYS Therapeutics Inc | 2004-11-01 |
| Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy (NCT00083720) | Eli Lilly and Company | 2004-10-01 |
| Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy (NCT01163110) | Midwestern Regional Medical Center | 2004-03-01 |
| A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. (NCT00199836) | Ludwig Institute for Cancer Research | 2003-09-03 |
| Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors (NCT00143533) | St. Jude Children's Research Hospital | 2003-09-01 |
| Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer (NCT00080418) | INSYS Therapeutics Inc | 2003-07-01 |
| Study of Karenitecin (BNP1350) to Treat Malignant Melanoma (NCT00062491) | BioNumerik Pharmaceuticals, Inc. | 2002-05-01 |
| Process and Outcomes of Pain Management (NCT00028249) | National Institutes of Health Clinical Center (CC) | 2001-12-01 |
| Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas (NCT00023166) | Enzon Pharmaceuticals, Inc. | 2001-05-01 |
| Iressa Expanded Access Program (EAP) (NCT00034879) | AstraZeneca | 2000-08-01 |
| Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria (NCT00004988) | National Cancer Institute (NCI) | 2000-03-01 |
| A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy (NCT00283465) | Janssen-Cilag B.V. | 1999-11-01 |
| A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning (NCT00026936) | National Cancer Institute (NCI) | 1999-05-01 |
| Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials (NCT00001695) | National Cancer Institute (NCI) | 1998-04-01 |
| Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer (NCT00026897) | National Cancer Institute (NCI) | 1997-12-01 |
| Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System (NCT00026871) | National Cancer Institute (NCI) | 1997-07-01 |
| Tissue Acquisition for Molecular Diagnostics (NCT00001580) | National Cancer Institute (NCI) | 1997-06-01 |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype (NCT00001572) | National Cancer Institute (NCI) | 1997-01-30 |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy (NCT00270127) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1996-08-01 |
| Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits (NCT00001500) | National Cancer Institute (NCI) | 1996-04-01 |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms (NCT00001444) | National Cancer Institute (NCI) | 1995-08-01 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy (NCT00270166) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-02-01 |
| Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts (NCT00026858) | National Cancer Institute (NCI) | 1994-10-01 |
| A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease (NCT00001341) | National Cancer Institute (NCI) | 1993-09-01 |
| In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients (NCT00001336) | National Cancer Institute (NCI) | 1993-04-01 |
| Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers (NCT00001150) | National Cancer Institute (NCI) | 1976-10-01 |
| Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies (NCT02955446) | University of Colorado, Denver | |
| Effectiveness of the FairCare System for Patients With Advanced Illness (NCT00105599) | US Department of Veterans Affairs | |
| Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients (NCT02473497) | Pfizer | |